Nkarta NKTX Stock
Nkarta Price Chart
Nkarta NKTX Financial and Trading Overview
| Nkarta stock price | 3.03 USD |
| Previous Close | 2.86 USD |
| Open | 2.89 USD |
| Bid | 2.11 USD x 200 |
| Ask | 3.6 USD x 200 |
| Day's Range | 2.78 - 2.98 USD |
| 52 Week Range | 1.63 - 3.65 USD |
| Volume | 535.99K USD |
| Avg. Volume | 746.35K USD |
| Market Cap | 199.61M USD |
| Beta (5Y Monthly) | 0.896 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.35 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.2 USD |
NKTX Valuation Measures
| Enterprise Value | 44.18M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.6173912 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.69576055 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.417 |
Trading Information
Nkarta Stock Price History
| Beta (5Y Monthly) | 0.896 |
| 52-Week Change | 59.42% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 3.65 USD |
| 52 Week Low | 1.63 USD |
| 50-Day Moving Average | 2.87 USD |
| 200-Day Moving Average | 2.3 USD |
NKTX Share Statistics
| Avg. Volume (3 month) | 746.35K USD |
| Avg. Daily Volume (10-Days) | 573.3K USD |
| Shares Outstanding | 71.55M |
| Float | 60.45M |
| Short Ratio | 7.26 |
| % Held by Insiders | 4.88% |
| % Held by Institutions | 80.55% |
| Shares Short | 5.23M |
| Short % of Float | 9.14% |
| Short % of Shares Outstanding | 7.30% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -17.097% |
| Return on Equity (ttm) | -30.070% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -106034000 USD |
| Net Income Avi to Common (ttm) | -99933000 USD |
| Diluted EPS (ttm) | -1.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 230.43M USD |
| Total Cash Per Share (mrq) | 3.22 USD |
| Total Debt (mrq) | 75M USD |
| Total Debt/Equity (mrq) | 26.24 USD |
| Current Ratio (mrq) | 12.956 |
| Book Value Per Share (mrq) | 4.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -87286000 USD |
| Levered Free Cash Flow (ttm) | -57381500 USD |
Profile of Nkarta
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 1150 Veterans Boulevard |
| ZIP | 94080 |
| Phone | 925 407 1049 |
| Website | https://www.nkartatx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 108 |
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Q&A For Nkarta Stock
What is a current NKTX stock price?
Nkarta NKTX stock price today per share is 3.03 USD.
How to purchase Nkarta stock?
You can buy NKTX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nkarta?
The stock symbol or ticker of Nkarta is NKTX.
Which industry does the Nkarta company belong to?
The Nkarta industry is Biotechnology.
How many shares does Nkarta have in circulation?
The max supply of Nkarta shares is 71.55M.
What is Nkarta Price to Earnings Ratio (PE Ratio)?
Nkarta PE Ratio is now.
What was Nkarta earnings per share over the trailing 12 months (TTM)?
Nkarta EPS is -1.35 USD over the trailing 12 months.
Which sector does the Nkarta company belong to?
The Nkarta sector is Healthcare.
Nkarta NKTX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12546.99 USD — |
-2.24
|
— — | 12513.27 USD — | 12692.24 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6185.56 USD — |
+0.85
|
— — | 6121.03 USD — | 6233.73 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}